133 Molesworth Street
PO Box 5013
Wellington 6140
New Zealand
T +64 4 496 2000
W www.medsafe.govt.nz
1 March 2023
ASE
By email: [FYI request #21747 email]
Ref:
H2023019885
Tēnā koe ASE
Response to your request for official information
Thank you for your request under the Official Information Act 1982 (the Act) to Manatū Hauora
(the Ministry of Health) on 7 February 2023. You requested:
“I am seeking all information held by The Ministry of Health relating to a temporal
correlation between COVID-19 “vaccines” and mortality.
I am seeking all information held by The Ministry of Health relating to any other correlations
between COVID-19 “vaccines” and mortality.
I am seeking all information held by The Ministry of Health relating to causality between
COVID-19 “vaccines” and mortality.
For clarification, this request includes all information pertaining to the above requests which
is, intentionally or otherwise, not being held by The Ministry of Health.”
On 10 February 2023 you provided the clarification below:
“To clarify the above referenced pending request: So far as it is practicable, I am seeking
information that reveals two categories: 1- Ever “vaccinated” against COVID-19, ie treated with a COVID-19 “vaccine” at any point
in time
2- Never “vaccinated” against COVID-19, ie not treated with a COVID-19 “vaccine” at any
point in time
If other category designations are used (eg “unvaccinated”, “partly vaccinated”, “fully
vaccinated”), please fully define the meanings of such designations.”
Despite your clarification, the information you have requested has not been made with the due
particularity required by section 12. Manatū Hauora is unable to respond to your request
confidently or comprehensively. Please note that section 12(2) of the Act requires that official
information requested shall be specified with due particularly for the requirements of the Act to
apply.
In order to provide reasonable assistance, please see below publicly available information
regarding the COVID-19 vaccine and Adverse Events Following Immunisation (AEFI), which we
believe may be the topic you are interested in.
Information concerning mortality in Aotearoa New Zealand can be found below:
www.health.govt.nz/publication/covid-19-mortality-aotearoa-new-zealand-inequities-risk. This has more information about mortality in New Zealand, COVID-19, and how access to the
COVID-19 vaccine provided a 62% reduction in the risk of death during the relevant analysis
period (page 4).
Information concerning Medsafe’s COVID-19 vaccine safety reports can be found at:
www.medsafe.govt.nz/COVID-19/vaccine-report-overview.asp.This provides further information
concerning the number and types of AEFI’s that have been reported to Medsafe.
Information concerning vaccine-mediated myocarditis death can be found at:
www.health.govt.nz/system/files/documents/pages/cv-ismb-interim-report-updated-july-
2022.pdf.This is a report from the COVID-19 Vaccine Independent Safety Monitoring Board
completed in July 2022. On page 21, the Board discusses and considers potential cases where
the COVID-19 may have caused a fatal reaction.
Case demographics are available on the Manatū Hauora website at:
www.health.govt.nz/covid-19-novel-coronavirus/covid-19-data-and-statistics/covid-19-case-
demographics.On this website you can find breakdowns of COVID-19 hospitalisations, ICU care
and deaths by vaccination status.
Under section 28(3) of the Act, you have the right to ask the Ombudsman to review any decisions
made under this request. The Ombudsman may be contacted by email at:
[email address] or by calling 0800 802 602.
Please note that this response, with your personal details removed, may be published on the
Manatū Hauora website at:
www.health.govt.nz/about-ministry/information-releases/responses-
official-information-act-requests. Nāku noa, nā
Chris James
Group Manager
Medsafe
Page 2 of 2
